Holdings of VIP Health Care Portfolio
Variable Insurance Products Fund IV · Original filing · Compare with another fund · Report an error
- Net assets
- 1B $ including 974.3M $ in equities, 97.0 %
- Positions
- 99 in 10 countries
- Top ten
- 40.3 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Danaher Corp | 360,000 | 68.3M $ | 6.80 % |
| 2 | Eli Lilly & Co | 72,800 | 67M $ | 6.67 % |
| 3 | Johnson & Johnson | 242,800 | 59.4M $ | 5.91 % |
| 4 | Boston Scientific Corp | 810,000 | 50.8M $ | 5.06 % |
| 5 | AbbVie Inc | 167,000 | 36.3M $ | 3.62 % |
| 6 | Gilead Sciences Inc | 186,000 | 25.9M $ | 2.58 % |
| 7 | UCB SA | 85,000 | 25.6M $ | 2.55 % |
| 8 | Merck & Co Inc | 210,000 | 25.3M $ | 2.52 % |
| 9 | Ascendis Pharma A/S | 110,000 | 25.2M $ | 2.50 % |
| 10 | Edwards Lifesciences Corp | 260,000 | 20.8M $ | 2.07 % |
| 11 | Alnylam Pharmaceuticals Inc | 60,000 | 19.9M $ | 1.98 % |
| 12 | Argenx SE | 26,800 | 19.6M $ | 1.95 % |
| 13 | Thermo Fisher Scientific Inc | 36,800 | 18.1M $ | 1.80 % |
| 14 | Insmed Inc | 98,000 | 16M $ | 1.60 % |
| 15 | Cencora Inc | 50,000 | 15.7M $ | 1.56 % |
| 16 | Cogent Biosciences Inc | 400,000 | 15.4M $ | 1.53 % |
| 17 | BrightSpring Health Services Inc | 350,000 | 14.9M $ | 1.48 % |
| 18 | Nuvalent Inc | 128,000 | 13.1M $ | 1.31 % |
| 19 | McKesson Corp | 15,000 | 13M $ | 1.29 % |
| 20 | UnitedHealth Group Inc | 46,500 | 12.6M $ | 1.25 % |
| 21 | Moderna Inc | 245,000 | 12.4M $ | 1.24 % |
| 22 | Xenon Pharmaceuticals Inc | 208,000 | 12.1M $ | 1.20 % |
| 23 | CVS Health Corp | 160,000 | 11.5M $ | 1.14 % |
| 24 | CENTESSA PHARMACEUTICALS PLC | 285,000 | 11.3M $ | 1.13 % |
| 25 | Caris Life Sciences Inc | 590,000 | 10.5M $ | 1.05 % |
| 26 | Vaxcyte Inc | 180,000 | 10.5M $ | 1.04 % |
| 27 | Royalty Pharma PLC | 215,000 | 10.3M $ | 1.03 % |
| 28 | Viridian Therapeutics Inc | 515,000 | 10.1M $ | 1.00 % |
| 29 | Medline Inc | 218,000 | 9.7M $ | 0.97 % |
| 30 | Roche Holding AG | 24,000 | 9.6M $ | 0.95 % |
| 31 | Repligen Corp | 78,000 | 9.2M $ | 0.91 % |
| 32 | Insulet Corp | 43,500 | 9.1M $ | 0.91 % |
| 33 | Veeva Systems Inc | 50,000 | 8.8M $ | 0.87 % |
| 34 | Enliven Therapeutics Inc | 218,000 | 8.5M $ | 0.85 % |
| 35 | Waystar Holding Corp | 354,000 | 8.5M $ | 0.85 % |
| 36 | Spyre Therapeutics Inc | 168,000 | 8.5M $ | 0.84 % |
| 37 | LEGEND BIOTECH CORP | 460,000 | 8.3M $ | 0.83 % |
| 38 | Privia Health Group Inc | 400,000 | 8.2M $ | 0.82 % |
| 39 | Oruka Therapeutics Inc | 162,159 | 8M $ | 0.79 % |
| 40 | Crinetics Pharmaceuticals Inc | 218,000 | 7.9M $ | 0.79 % |
| 41 | Veracyte Inc | 240,000 | 7.7M $ | 0.77 % |
| 42 | Bio-Techne Corp | 140,000 | 7.3M $ | 0.73 % |
| 43 | Disc Medicine Inc | 114,000 | 7.3M $ | 0.73 % |
| 44 | Kiniksa Pharmaceuticals International Plc | 150,000 | 7.2M $ | 0.72 % |
| 45 | Intuitive Surgical Inc | 15,500 | 7.1M $ | 0.71 % |
| 46 | CG oncology Inc | 105,000 | 7.1M $ | 0.71 % |
| 47 | Praxis Precision Medicines Inc | 21,800 | 7M $ | 0.70 % |
| 48 | 10X Genomics Inc | 328,000 | 7M $ | 0.69 % |
| 49 | Cytokinetics Inc | 100,000 | 6.6M $ | 0.66 % |
| 50 | Alignment Healthcare Inc | 360,000 | 6.3M $ | 0.63 % |
| 51 | Kymera Therapeutics Inc | 76,000 | 6.3M $ | 0.63 % |
| 52 | Roivant Sciences Ltd | 228,000 | 6.3M $ | 0.63 % |
| 53 | West Pharmaceutical Services Inc | 25,000 | 6.3M $ | 0.62 % |
| 54 | Axsome Therapeutics Inc | 35,000 | 5.9M $ | 0.59 % |
| 55 | LifeStance Health Group Inc | 860,000 | 5.5M $ | 0.55 % |
| 56 | Stryker Corp | 15,600 | 5.1M $ | 0.51 % |
| 57 | Structure Therapeutics Inc | 106,000 | 5.1M $ | 0.51 % |
| 58 | Sartorius Stedim Biotech | 25,000 | 4.9M $ | 0.48 % |
| 59 | Mineralys Therapeutics Inc | 175,000 | 4.7M $ | 0.47 % |
| 60 | HeartFlow Inc | 194,000 | 4.7M $ | 0.47 % |
| 61 | BEONE MEDICINES LTD | 15,000 | 4.5M $ | 0.44 % |
| 62 | Cigna Group/The | 16,500 | 4.4M $ | 0.44 % |
| 63 | Guardant Health Inc | 45,000 | 4.2M $ | 0.41 % |
| 64 | CytomX Therapeutics Inc | 860,000 | 4M $ | 0.40 % |
| 65 | Olema Pharmaceuticals Inc | 265,000 | 4M $ | 0.39 % |
| 66 | Stoke Therapeutics Inc | 120,000 | 3.9M $ | 0.39 % |
| 67 | Newamsterdam Pharma Co NV | 115,000 | 3.7M $ | 0.37 % |
| 68 | ZENAS BIOPHARMA INC | 185,000 | 3.6M $ | 0.36 % |
| 69 | Pharvaris NV | 128,000 | 3.6M $ | 0.36 % |
| 70 | Amylyx Pharmaceuticals Inc | 260,000 | 3.6M $ | 0.36 % |
| 71 | Summit Therapeutics Inc | 180,000 | 3.4M $ | 0.34 % |
| 72 | Viking Therapeutics Inc | 100,000 | 3.3M $ | 0.32 % |
| 73 | Mirum Pharmaceuticals Inc | 35,000 | 3.2M $ | 0.32 % |
| 74 | Kestra Medical Technologies Ltd | 160,000 | 3.2M $ | 0.32 % |
| 75 | BioNTech SE | 35,000 | 3.1M $ | 0.31 % |
| 76 | DAMORA THERAPEUTICS INC | 118,000 | 3.1M $ | 0.30 % |
| 77 | Travere Therapeutics Inc | 100,000 | 3M $ | 0.30 % |
| 78 | IRhythm Holdings Inc | 25,000 | 3M $ | 0.29 % |
| 79 | Dianthus Therapeutics Inc | 32,000 | 2.7M $ | 0.27 % |
| 80 | Immunocore Holdings PLC | 84,000 | 2.5M $ | 0.25 % |
| 81 | Soleno Therapeutics Inc | 67,000 | 2.2M $ | 0.22 % |
| 82 | Trevi Therapeutics Inc | 180,000 | 2.1M $ | 0.21 % |
| 83 | Scholar Rock Holding Corp | 39,900 | 2M $ | 0.20 % |
| 84 | Tyra Biosciences Inc | 50,000 | 1.9M $ | 0.19 % |
| 85 | Biogen Inc | 10,000 | 1.8M $ | 0.18 % |
| 86 | Revolution Medicines Inc | 18,000 | 1.8M $ | 0.17 % |
| 87 | Apogee Therapeutics Inc | 19,277 | 1.6M $ | 0.16 % |
| 88 | MBX Biosciences Inc | 50,000 | 1.5M $ | 0.15 % |
| 89 | Upstream Bio Inc | 145,000 | 1.3M $ | 0.13 % |
| 90 | IQVIA Holdings Inc | 6,800 | 1.2M $ | 0.12 % |
| 91 | Annexon Inc | 200,000 | 1.1M $ | 0.11 % |
| 92 | Outset Medical Inc | 280,000 | 1.1M $ | 0.11 % |
| 93 | Contineum Therapeutics Inc | 80,000 | 1M $ | 0.10 % |
| 94 | JADE BIOSCIENCES INC | 60,000 | 843K $ | 0.08 % |
| 95 | Ocular Therapeutix Inc | 83,621 | 708.3K $ | 0.07 % |
| 96 | Immunome Inc | 11,100 | 242.8K $ | 0.02 % |
| 97 | Shoulder Innovations Inc | 16,100 | 233.9K $ | 0.02 % |
| 98 | Acumen Pharmaceuticals Inc | 95,526 | 225.4K $ | 0.02 % |
| 99 | SALUDA MEDICAL INC | 300,000 | 172.4K $ | 0.02 % |
Sector breakdown
- Health care 56.8 %
- Technology 0.9 %
- Unattributed 42.3 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 95.9 %
- EUR 3.1 %
- CHF 1.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 87.2 %
- Netherlands 2.8 %
- Belgium 2.6 %
- Denmark 2.6 %
- Canada 1.2 %
- Switzerland 1.0 %
- Bermuda 1.0 %
- Cayman Islands 0.9 %
- France 0.5 %
- Germany 0.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 87 | 849.2M $ | 87.16 % |
| 2 | Netherlands | 3 | 26.9M $ | 2.76 % |
| 3 | Belgium | 1 | 25.6M $ | 2.63 % |
| 4 | Denmark | 1 | 25.2M $ | 2.58 % |
| 5 | Canada | 1 | 12.1M $ | 1.24 % |
| 6 | Switzerland | 1 | 9.6M $ | 0.98 % |
| 7 | Bermuda | 2 | 9.5M $ | 0.98 % |
| 8 | Cayman Islands | 1 | 8.3M $ | 0.85 % |
| 9 | France | 1 | 4.9M $ | 0.50 % |
| 10 | Germany | 1 | 3.1M $ | 0.32 % |
Cite this page
Titelia. "Holdings of VIP Health Care Portfolio". https://titelia.com/en/funds/S000007742